Geoffrey OBrien - 27 Jan 2022 Form 4 Insider Report for MEDICINOVA INC (MNOV)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MNOV	Employee Stock Option (Right to Buy)	Award	$0	+99,000		$0.000000	99,000	27 Jan 2022	Common Stock	99,000	$5.92	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	On February 18, 2021, the reporting person was granted an option to purchase 180,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2021. Such performance criteria for 2021 were achieved at the 55% attainment level, resulting in vesting of the option as to 99,000 shares.